Aspira Womans Health Inc (AWHL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,094 | -16,690 | -29,885 | -31,662 | -17,905 |
| Depreciation Amortization | 92 | 199 | 264 | 302 | 265 |
| Accounts receivable | 469 | -214 | -218 | -162 | 59 |
| Other Working Capital | 697 | 225 | -2,799 | 1,394 | 1,329 |
| Other Operating Activity | -277 | 586 | 1,570 | 2,733 | 1,518 |
| Operating Cash Flow | $-12,113 | $-15,894 | $-31,068 | $-27,395 | $-14,734 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -37 | -24 | -232 | -184 | -490 |
| Investing Cash Flow | $-37 | $-24 | $-232 | $-184 | $-490 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 3,006 |
| Debt Repayment | -93 | -148 | -261 | -198 | -192 |
| Common Stock Issued | 904 | 4,918 | 9,013 | 48,576 | 6,697 |
| Other Financing Activity | 10,253 | 446 | -1,325 | 0 | 10,641 |
| Financing Cash Flow | $11,064 | $5,216 | $7,427 | $48,378 | $20,152 |
| Beginning Cash Position | 2,855 | 13,557 | 37,430 | 16,631 | 11,703 |
| End Cash Position | 1,769 | 2,855 | 13,557 | 37,430 | 16,631 |
| Net Cash Flow | $-1,086 | $-10,702 | $-23,873 | $20,799 | $4,928 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,113 | -15,894 | -31,068 | -27,395 | -14,734 |
| Capital Expenditure | -37 | -24 | -232 | -184 | -490 |
| Free Cash Flow | -12,150 | -15,918 | -31,300 | -27,579 | -15,224 |